2021 annual financial data
Inhibikase Therapeutics, Inc. 2021 Net margin
Inhibikase Therapeutics, Inc. 2021 net margin with verified reported values.
Direct answer
Net margin was -477.52%.
Operating income was -14,766,140 USD and net income was -14,805,986 USD.
Operating cash flow was -14,297,051 USD.
Get free Inhibikase Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,100,605 USD
- Operating income
- -14,766,140 USD
- Net income
- -14,805,986 USD
- Operating cash flow
- -14,297,051 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Inhibikase Therapeutics, Inc. financial years